Business
Half Yearly Report
Half Yearly Report.
About this update from Emv Capital Plc
[{"type":"text","content":"\n \nRNS Number : 3136S NetScientific PLC 23 September 2014 \n \n\n \nNetScientific plc\n('NetScientific' or 'the Company' or 'the Group')\n \nHalf-Yearly Report \n \n \n23 September 2014: NetScientific (AIM: NSCI), the global biomedical and healthcare technology group today announces its half yearly report for the six months ended 30 June 2014. \n \nHighlights\n \n§ Significant progress made in advancing the technologies in two core subsidiaries, WandaHealth and Vortex Biosciences. \n \n§ New commercial partnership with Peter Thiel's Breakout Labs which provides \nNetScientific with direct access to cutting-edge technologies in Silicon Valley.\n \n§ Post period end investments were made in two new later-stage companies, G-Tech Medical and Longevity Biotech.\n \n§ Strict expenditure controls and rigorous criteria for new investments resulted in higher than budget closing cash balance of £22.5 million.\n \nFarad Azima, CEO of NetScientific, said: \n \n\"The Group has made significant progress so far this year in bringing our subsidiaries closer to achieving value inflection points which will allow a series of high performance exits. At NetScientific our view is that, science knows no borders. Therefore, we anticipate securing further additional strategic alliances, which will give us worldwide access to other transformative technologies.\" \n \n-Ends-\n \nFor more information, please visit the website at www.netscientific.net.\n \nContact Details\n \n\n\n\n\nNetScientific plc \nFarad Azima\nPeter Thoms\n\n\nTel: +44 (0) 20 3290 8877\n\n\n\n\n\n\n\n\n\n\n\n\nLiberum (NOMAD and Broker)\nChris Bowman / Christopher Britton / Thomas Bective\n\n\nTel: +44 (0)20 3100 2000\n\n\n\n\n\n\n\n\n\n\n\n\nInstinctif Partners \nMelanie Toyne-Sewell / Tim Watson\n\n\nTel: +44 (0) 20 7457 2020\nEmail: [email protected]\n\n\n\n\n\n \nCopies of the unaudited interim results for the six months ended 30 June 2014 are available on the Group's website at www.netscientific.net.\n\n \n \nOverview\nOver the six-month period under review, the Group made significant progress, in particular in two of its core subsidiaries, WandaHealth and Vortex Biosciences. Strict expenditure controls and rigorous criteria for new investments resulted in higher than budg...